Tom Price has tried to block efforts by Medicare to scale back payments for expensive chemotherapy and to limit large payments for hip and knee replacements. There isn't consensus in the medical community about his appointment.
In picking Tom Price to be secretary of Health and Human Services, Donald Trump has chosen an orthopedic surgeon who in his congressional career, has loyally promoted the interests of the medical profession —its freedom and importantly, its financial interests.
A conservative representing Georgia's 6th District, Price sponsored a 2015 bill that would restrict efforts to reduce doctor payments for medical services. He cosponsored another 2011 bill that would have limited reports used by hospitals and regulators to perform background checks used to screen doctors before hiring them.
A fierce critic of Obamacare, Price has tried to block efforts by Medicare to scale back payments for expensive chemotherapy and to limit large payments for hip and knee replacements. He also has taken the lead in trying to impose federal controls on medical malpractice suits.
Most of Price's proposals stalled in Congress, but he now stands a better chance of implementing his ideas with a powerful cabinet position and a Republican-controlled White House and Congress.
"Instead of having a secretary for the people, you have a secretary for the medical profession," said Max Mehlman, a law professor at Case Western University, who specializes in medical malpractice and reviewed Price's proposal.
The American Medical Association, the doctors' professional group whose members are among Price's top campaign supporters, says he brings a unique perspective to the job of HHS secretary, a role traditionally filled by foundation executives, career politicians, social scientists, lawyers and public health experts.
The most recent physician to hold the position was Dr. Louis Sullivan who served under George H.W. Bush and was the founding president of Morehouse School of Medicine, as well as an expert on health care in minority populations.
"As a lawmaker, Dr. Price has had the valuable ability to see how legislation and regulation would affect patients and their physicians," Dr. Patrice Harris, chair of the AMA board of trustees, said in a statement to Kaiser Health News.
Price, who founded a large orthopedic practice in suburban Atlanta, did not respond to interview requests. He came to Congress with strong backing from medical interests, including the AMA and trade groups representing orthopedic doctors, dentists and anesthesiologists, according to campaign finance data compiled by the nonprofit, nonpartisan Center for Responsive Politics.
But there isn't consensus in the medical community about his appointment. Within days, more than 4,800 physicians from a wide array of backgrounds signed a petition protesting his appointment.
"Dr. Price's proposed policies threaten to harm our most vulnerable patients and limit their access to health care," wrote the group, citing his stance on Medicaid. "Dr. Price purports to care about efficiency, while opposing innovations by the Centers for Medicare & Medicaid to improve value and eliminate waste in health care."
Price describes himself as the "go-to Republican on quality health care policy," according to his website. He mobilized GOP opposition to the Affordable Care Act and proposed alternate plans, the most recent in May 2015, called the Empowering Patients First Act.
In a recent interview with Radio America, Price said increases in insurance premiums and deductibles show the failures of Obamacare.
"We opposed the plan because it doesn't work for people, it doesn't work for patients," Price said.
Price's alternative includes health care saving accounts to help individuals pay for health insurance, a concept now embraced by the Trump team.
But the bill also includes fine print calling for "lawsuit abuse reforms" that would allow the HHS secretary to give states money to create tribunals to review malpractice claims. The process would make it more difficult for patients to prove medical error, setting the standard at "gross negligence."
Chip Wagar, a New Orleans malpractice lawyer who advises a patient advocacy group, said Price's proposal, if implemented, would mean that "checks and balances that have been in place, which are already friendly to the medical profession, would be even further tilted away from patient and victims' rights."
The AMA did not support Price's 2015 bill, although it has supported specialized health courts.
In 2011, Price cosponsored a bill that would limit reports to the National Practitioner Data Bank, a confidential repository of information, such as malpractice judgments and hospital discipline, about doctors and other health professionals. The information is used by health licensing boards and hospitals making hiring decisions.
The bill, which died in committee with 15 GOP co-sponsors, would have allowed physicians to contest reports to the data bank by hospitals that deny doctors' access to their facilities due to questionable performance.
Dr. Michael Carome, director of Public Citizen's Health Research Group, a consumer advocacy group, said the proposal would have made it more difficult for hospitals to adequately oversee physicians.
"Dr. Price is a physician who is just obviously responding to pressure from colleagues in the medical field who'd like to be exempt from being held accountable," said Carome, who also reviewed Price's malpractice proposal.
Price has also criticized some Obama administration efforts to cut health costs, citing too much government interference. His Obamacare replacement bill would bar states from limiting doctors' charges for medical services.
Price opposed a Medicare proposal intended to rein in spending for medications doctors administer to patients, such as intravenous chemotherapy drugs. Medicare officials have said spending on such drugs went from $3 billion in 2007 to $8 billion in 2015.
The change, which has not been approved, would have eliminated incentives for doctors and hospitals that earn higher payments by prescribing more expensive drugs.
Price cosponsored a bill in March to block final implementation of the proposal, saying it would harm vulnerable patients by limiting their access to care.
Price had the first signature on a letter backed by more than 200 Congress members, saying the proposal would force some doctors — particularly those in small practices — to lose money. "The impact on patients will be sweeping and affect seniors across the country," the letter says.
The nonpartisan Congressional Budget Office estimated that Price's proposal to ax drug pricing limits would cost taxpayers $395 million from 2016 to 2026.
Price sought to delay implementation of another plan to pay doctors a flat rate for joint replacement surgery, eliminating situations where Medicare covers the added costs of patient infections or prolonged physical therapy.
Tom Miller, a resident fellow with the American Enterprise Institute, a conservative think tank, said Price's opposition to cost-cutting proposals arises from a free market philosophy that less government intervention is better.
"Many of those objections are to how the cost cutting are being done — a brute-force, top-down bureaucratic approach," he said. "His opposition is to government control of more aspects of health care — that's the driving force. It's a shared point of view if you're a Republican conservative doctor."
Even some critics of Price's proposals are hopeful his experience will prompt him to tackle cost-cutting and improve patient-care quality as HHS secretary.
"He has been a loyal Republican and a champion of conservative causes that I don't support," said William Sage, a University of Texas at Austin law professor who has studied medical malpractice and health care costs. "Far more important is that as someone with deep inside knowledge of health care he understands how overpriced health care delivery is and how disorganized and often ineffective it is."
Among Republican ideas to transform the health care system is a proposal to allow health insurers to sell their policies across state lines.
President-elect Donald Trump and Rep. Tom Price, the Georgia congressman picked by Trump to lead the Department of Health and Human Services, have backed the proposal. They and other advocates see it as a way to boost competition. The interstate sales idea is part of a general GOP blueprint to replace the 2010 Affordable Care Act, often called Obamacare.
In Georgia, the interstate sale of health insurance has already had a five-year tryout.
The state legislature in 2011 passed a bill letting insurers sell any policies in Georgia that they offer in other states. The legislation was hailed by supporters and business groups as a way to skirt the state's required benefit coverages — such as screenings for cervical, prostate and colorectal cancer, along with mammograms — and thus lower the sticker price of insurance.
The law is still in effect. But since it was passed, no health insurer has taken advantage of it.
And since January, an obscure provision of the ACA has been in effect, letting individual states agree among themselves to allow sales by one another's health insurance companies. Although several states have passed laws to move toward such a compact, none has made any deals to sell across state lines, insurance experts and regulators told The Hill in October.
Each state has its own set of health insurance regulations, though large employers that self-insure (those that use their own funds to cover employees' health expenses) are exempt from these state rules.
Currently, the idea of eliminating barriers to interstate sales is drawing some opposition from state insurance regulators and insurance industry officials, The Wall Street Journal reported last week. "That sounds like a silver bullet to solve a major problem, and there are no silver bullets," said Louisiana Insurance Commissioner Jim Donelon. "There are no simple answers."
Some Democrats have voiced concern about the erosion of state consumer protections.
Graham Thompson, executive director of the Georgia Association of Health Plans, an industry group, said Wednesday that the GOP proposals aimed at helping health insurers are "a positive change in tune'' after industry losses suffered under the Affordable Care Act.
A federal law allowing interstate sales across the country "could be different'' from the more limited Georgia experience, Thompson said. "We'll have to see the details."
He said that one obstacle to insurers selling out-of-state policies in Georgia is that "all health care is local — and all health care costs are local." So insurers would still have to strike contracts with local hospitals and other medical providers, Thompson noted.
Bill Custer, a health insurance expert at Georgia State University, said a handful of other states have passed interstate insurance laws similar to Georgia's, but the effect has been the same.
State insurance regulators told the Journal that in states requiring locally licensed insurers to offer extensive coverage, healthy people might abandon those companies to buy bare-bones policies from out of state. That, in turn, would leave local plans insuring mostly people with health problems, who need broader, more expensive coverage. As the locally registered insurance companies absorb the financial hit, the state might feel pressure to relax standards to give them a break.
But the proposals pushed by Price and House Speaker Paul Ryan (R-Wis.) would still require a minimum set of essential benefits at the federal level in order to qualify for tax credits, said Custer of Georgia State. So the effect of interstate insurance could be minimal, he said.
"It's unlikely to have a large effect on competition in any market,'' he said.
An industry trade group, America's Health Insurance Plans, said in a statement to Georgia Health News on Wednesday that "our first interest is in providing consumers with competition and choice, which empowers them to better health and financial stability. We want to work with lawmakers to bring our experience and lessons learned to the table, and we want to cooperate and collaborate to find solutions that work for consumers.''
Cindy Zeldin, executive director of consumer group Georgians for a Healthy Future, said interstate sales "would erode rights and protections for health care consumers, complicate their efforts to find in-network providers, and do little to nothing to improve affordability.''
More than 500,000 Georgians are at risk of losing their coverage if the ACA is repealed without an adequate replacement, she said. "Buying a health insurance plan from Texas or Idaho isn't going to solve the problem, and would leave consumers in Georgia with little recourse if they were treated unfairly by an insurance company based in another state or in cases of fraud."
Prompted by a state law that took effect this year, a coalition of emergency and social service providers is working to create an electronic registry that will be accessible to first responders and medical providers.
CONCORD, Calif. — Mary De Freze, who has heart problems, chronic lung disease and a history of falling, knows she may not have too many years left. And she's clear about what she wants — and doesn't want — at the end of her life.
"I don't want to be in a lot of pain and I don't want to be kept alive by machines," said De Freze, 81.
After a recent fall landed De Freze in Stonebrook Healthcare Center with cracked ribs and a bruised spleen, the staff there helped her put those wishes on paper.
The document they used, Physician Orders for Life-Sustaining Treatment, or POLST, gives patients a choice of how much medical care they want in an emergency.
Prompted by a state law that took effect this year, a coalition of emergency and social service providers is working to create an electronic registry for POLST forms so they will be available to first responders and medical providers when they are needed. The group is starting with a three-year pilot project in San Diego and Contra Costa counties that could serve as a model for a single, statewide registry. Paper-based POLST forms are used across the nation, but electronic registries exist only in a few states, including Oregon, New York and West Virginia.
Many adults have advance directives, which are legal documents that designate a surrogate decision-maker and list patients' health care preferences. POLST forms go further, creating a set of medical orders that are signed by the provider and the patient or a legally recognized decision-maker. Unlike advance directives, they are specifically designed for people who are already seriously ill or near the end of life.
Research shows that POLST forms help ensure patients' end-of-life wishes are followed. But that only happens if doctors and other emergency providers can get them quickly. In California, the POLST form is a paper document and might not be at hand when patients need it. In many situations — a heart attack, a stroke or severe dementia — patients may not be able to communicate. And doctors may not be able to reach their families right away.
Without information on what patients want, there is an increased chance their wishes won't be followed.
"If you take the time to fill out a POLST form, you want your health care wishes to be known and respected," said Kate O'Malley, a senior program officer at the California Health Care Foundation, which is funding the pilot project in California. (California Healthline is an editorially independent service of the California Health Care Foundation.)
A POLST registry "would be a big plus for being able to give people the care they want and not give them the care they don't want," said Jeffrey Klingman, a neurologist at Kaiser Permanente in the East Bay.
"I don't want to do things to people they don't want done," he said. "On the other hand, I don't want to delay treatment while I wait to figure out what they want done."
Oregon was the first state to use POLST forms in 1991. California has been using them for nearly 20 years. Filling out the forms is voluntary, but once they are completed and signed, they must be followed, and providers have immunity from criminal prosecution or civil liability when they do so in good faith. The forms are printed on bright pink paper and include decisions such as whether a patient should be resuscitated, admitted to the intensive care unit or have a feeding tube inserted.
Tony Chicotel, a staff attorney at California Advocates for Nursing Home Reform in San Francisco, said patients should document their wishes in advance but that there are some downsides to doing so only with POLST forms. They are not nearly as thorough as advance directives and don't allow you to designate a decision-maker, he noted. "The most comprehensive health care planning you can do is to name an agent."
In addition, Chicotel said many nursing home residents are being urged to complete POLST forms even if they aren't seriously ill or at the end of life. He said if an electronic registry is created, it should also include advance health care directives.
California's electronic registry would be a secure, cloud-based portal for medical providers to submit and view POLST forms, regardless of whether the patient was at home, in the hospital or at a nursing home.
An electronic registry is a "no-brainer," said Judy Thomas, CEO of the Coalition for Compassionate Care of California, which coordinates the state's POLST program. But implementation will be much harder because it will require the cooperation of state agencies, doctors, emergency personnel, and private and public health systems. Success will also depend in part on hospitals' willingness to share records.
"We are not asking all health systems to share all information," said Allen Namath, co-founder of Vynca, the technology vendor for the project. "But the value in these forms is being able to share them."
Patients who go through the trouble of documenting their medical preferences shouldn't have to worry about getting the wrong care, he said. "It is not a cardiology problem. It is not a cancer problem. Helping improve our end-of-life care … applies to everybody."
San Diego County already has a health information exchange that allows hospitals and health systems to share some data. But Contra Costa County is further behind.
"It's going to be challenging," said Donald Waters, executive director of the Alameda-Contra Costa Medical Association, which is helping lead the pilot project.
But Waters said it's worth the effort to overcome the hurdles because having documents uploaded means paramedics and others will know in an instant if patients want to be resuscitated or just kept comfortable.
Situations arise every day in which being able to access POLST forms electronically could improve end-of-life care, said Tom Sugarman, an emergency physician at Sutter Delta Medical Center in Antioch, Calif.
"If you come [to the hospital] in full cardiac arrest … we only have one or two minutes to make a decision," said Sugarman, who educates doctors about POLST. "All physicians are going to err on the side of preserving life."
Sometimes, however, a patient may prefer comfort care, Sugarman said. A POLST form — if it is available — means families don't have to make decisions during an emergency, he said. "The worst time to have that conversation is during a crisis."
At Chaparral House, a nursing home in Berkeley, the POLST forms are in the residents' folders at the nursing station. The forms go with patients to the hospital, but sometimes there is still a disconnect. Administrator KJ Page recalls one resident getting a feeding tube when he didn't want one and another who almost underwent bypass surgery against his wishes.
Audrey de Jesus, 83, arrived at Chaparral House just a few months ago. She uses a wheelchair and an oxygen tank. Beside her bed sits a Bible and a book of Psalms.
De Jesus has seven children and said the form tells them exactly what she wants — comfort-focused treatment — so there aren't any questions in an emergency. "I want pain control and the least suffering for my family," she said.
Stonebrook Healthcare Center Social Services Director Shirley Jackson said filling out POLST forms is part of the admission process. "It's almost like a driver's license for the end of your life," she said. "It's important."
Having the form available electronically would make it much easier for everyone. "If, God forbid, you have to send somebody out in an emergency, especially if they are unresponsive, it's right there in the chart," she said.
De Freze, a former certified nursing assistant, said she plans to put her pink form on her refrigerator when she leaves Stonebrook. She knows she could have an emergency and may not be able to tell doctors or paramedics what she wants.
"You can't communicate if you are in excruciating pain," she said.
Approximately three-quarters of health care and hospital systems ask for "point-of-service collections," estimates a Healthcare Financial Management Association executive.
Tai Boxley needs a hysterectomy. The 34-year-old single mother has uterine prolapse, a condition that occurs when the muscles and ligaments supporting the uterus weaken, causing severe pain, bleeding and urine leakage.
Boxley and her 13-year-old son have health insurance through her job as an administrative assistant in Tulsa, Okla. But the plan has a deductible of $5,000 apiece, and Boxley's doctor said he won't do the surgery until she prepays her share of the cost. His office estimates that will be as much as $2,500. Boxley is worried that the hospital may demand its cut as well before the surgery can be performed.
"I'm so angry," Boxley said. "If I need medical care I should be able to get it without having to afford it up front."
At many doctors' offices and hospitals, a routine part of doing business these days is estimating patients' out-of-pocket payments and trying to collect it up front. Eyeing retailers' practice of keeping credit card information on file, "there's certainly been a movement by health care providers to store some of this information and be able to access it with patients' permission," said Mark Rukavina, a principal at Community Health Advisors in Chestnut Hill, Mass., who works with hospitals on addressing financial barriers to care.
But there's a big difference between handing over a credit card to cover a $20 copayment versus suddenly being confronted with a $2,000 charge to cover a deductible, an amount that might take months to pay off or exceed a patient's credit limit. Doctors may refuse to dispense needed care before the payment is made, even as patient health hangs in the balance.
The strategy leaves patients financially vulnerable too. Once a charge is on a patient's credit card, they may have trouble contesting a medical bill. Likewise, a service placed on a credit card represents a consumer's commitment that the charge was justified, so nonpayment is more likely to harm a credit score.
Approximately three-quarters of health care and hospital systems ask for payment at the time services are provided, a practice known as "point-of-service collections," estimated Richard Gundling, a senior vice president at the Healthcare Financial Management Association, an industry group. He could not say how many were doing so for higher priced services or for patients with high-deductible plans, situations that would likely result in out-of-pocket outlays of hundreds or thousands of dollars.
"For providers, there's more risk with these higher deductibles, because the chance of being able to collect it later diminishes," Gundling said.
But the practice leaves many patients resentful.
After arriving by ambulance at the emergency department, Susan Bradshaw lay on a gurney in her hospital gown with a surgical bonnet on her head, waiting to be wheeled into surgery to remove her appendix at a hospital near her home in Maitland, Fla. A woman in street clothes approached her. Identifying herself as the surgeon's office manager she demanded that Bradshaw make her $1,400 insurance payment before the surgery could proceed.
"I said, 'You have got to be kidding. I don't even have a comb,'" Bradshaw, a 68-year-old exhibit designer, told the woman on that night eight years ago. "I don't have a credit card on me."
The woman crossed her arms and Bradshaw remembers her saying, "You have to figure it out."
As providers aim to maximize their collections, many contract with companies that help doctors and hospitals secure payments up front, often providing scripts that prompt staff to talk with patients about their payment obligations and discuss payment scenarios as well as software that can estimate what a patient will owe.
But as hospitals and doctors push for point-of-service payments to reduce bad debt from patients with increasingly high deductibles, the risk is that patients will delay care and end up in the emergency room, Rukavina said. "Patients are essentially paying for their procedures up front," he said. "It may not be a significant amount compared to their salary, but they don't necessarily have it available at the time of service."
The higher their deductible, the less likely patients are to pay what they owe, according to an analysis of 400,000 claims by the Advisory Board, a health care research and consulting firm. While more than two-thirds of patients with a deductible of less than $1,000 were likely to pay at least some portion of what they owe, just 36 percent of those with deductibles of more than $5,000 did so, the analysis found.
Fifty-one percent of workers with insurance through their employer had a deductible of at least $1,000 for single coverage this year, according to the Kaiser Family Foundation's annual survey of employer health insurance. (KHN is an editorially independent program of the foundation.)
Boxley pays $110 a month for her family plan. She could not afford the premiums on plans with lower deductibles that her employer offered. She plans to talk with the doctor and hospital about setting up a payment plan so she can get the surgery in January.
"I'll make payments," Boxley said, although she acknowledged what she could pay monthly would be small. If that doesn't pan out, she figures she'll have to use student loan money she got for graduate school to cover what she owes.
Still, experts say that trying to pin patients down for payment in more acute settings, such as the emergency department, may cross a line.
Under the federal Emergency Medical Treatment and Labor Act (EMTALA), a patient who has a health emergency has to be stabilized and treated before any hospital personnel can discuss payment with them. If it's not an emergency, however, those discussions can occur before treatment, said Dr. Vidor Friedman, an emergency physician who is the secretary-treasurer of American College of Emergency Physicians' board of directors.
Bradshaw finally got her appendix removed by calling a friend, who read his MasterCard number over the phone. The surgery was uneventful and Bradshaw was home within 24 hours.
"It's a very murky, unclear situation," Friedman said of Bradshaw's experience, noting that a case might be made that her condition wasn't life threatening. "At the very least it's poor form, and goes against the intent if not the actual wording of EMTALA."
A sprawling health bill expected to pass the Senate and become law before the end of the year is a grab bag for industries that spent plenty of money lobbying to make sure it happened that way.
Here are some of the winners and losers in the 21st Century Cures Act:
Winners
Pharmaceutical and Medical Device Companies. The bill will likely save drug and device companies billions of dollars bringing products to market by giving the Food and Drug Administration new authority and tools to demand fewer studies from those companies and speed up approvals.
The changes represent a massive lobbying effort by 58 pharmaceutical companies, 24 device companies and 26 "biotech products and research" companies, according to a Kaiser Health News analysis of lobbying data compiled by the Center for Responsive Politics. The groups reported more than $192 million in lobbying expenses on the Cures Act and other legislative priorities, the analysis shows.
Medical schools, hospitals and physicians. The bill provides $4.8 billion over 10 years in additional funding to National Institutes of Health, the federal government's main biomedical research organization. (The funds are not guaranteed, however, and will be subject to annual appropriations.)
The money could help researchers at universities and medical centers get hundreds of millions more dollars in research grants, most of it toward research on cancer, neurobiology and genetic medicine.
The bill attracted lobbying activity from more than 60 schools, 36 hospitals and several dozen groups representing physician organizations. They reported spending more than $120 million in disclosures that included Cures Act lobbying.
Mental health and substance abuse advocates. The bill provides $1 billion in state grants over two years to address opioid abuse and addiction. While most of that money goes to treatment facilities, some will fund research.
The bill also boosts funding for mental health research and treatment, with hundreds of millions of dollars authorized for dozens of existing and new programs.
Mental health, psychology and psychiatry groups spent $1.8 million on lobbying disclosures that included the Cures bill as an issue.
Patient groups. Specialty disease and patient advocacy groups supported the legislation and lobbied vigorously. Many of these groups get a portion of their funding from drug and device companies. The bill includes more patient input in the drug development and approval process, and the bill is a boost to the clout of such groups.
More than two dozen patient groups lobbied the bill, and reported spending $6.4 million in disclosures that named the bill as one of their issues.
Health information technology and software companies. The bill pushes federal agencies and health providers nationwide to use electronic health records systems and to collect data to enhance research and treatment. Although it doesn't specifically fund the effort, IT and data management companies could gain millions of dollars in new business.
More than a dozen computer, software and telecom companies reported Cures Act lobbying. The groups' total lobbying spending was $35 million on Cures as well as other legislation.
Losers
Preventive medicine. The bill cuts $3.5 billion — about 30 percent — from the Prevention and Public Health Fund established under Obamacare to promote prevention of Alzheimer's disease, hospital acquired infections, chronic illnesses and other ailments.
Consumer and patient safety groups. Groups like Public Citizen and the National Center for Health Research either fought the law outright or sought substantial changes. Although they won on some points, these groups still say Cures opens the door for unsafe drug and device approvals and doesn't address rising drug costs.
Hair growth patients. The bill says federal Medicaid will no longer help pay for drugs that help patients restore hair. The National Alopecia Areata Foundation spent $40,000 on lobbying disclosures this cycle that included Cures.
The FDA. The bill gives the FDA an additional $500 million through 2026 and more hiring power, but critics say it isn't enough to cover the additional workload under the bill. The agency also got something it opposed: renewal of a controversial voucher program that awards companies that approve drugs for rare pediatric diseases.
The Obama administration has agreed that the increasing supply of fentanyl on the street is a major challenge and said agencies are doing a lot. But reducing the supply is complicated.
The latest chart of overdose deaths in Massachusetts shows a climbing blue line labeled "fentanyl." Pick a spot on that line in mid-August and picture a big, affable 40-year-old man named Joe Salemi. He died at his mom's home in working-class Everett, Mass., after almost 25 years of heroin use.
Salemi had overdosed before. His brother Anthony Salemi said he was pretty sure, at the time, that something besides heroin killed Joe. The medical examiner later confirmed it.
"I knew, deep in my mind, it was going to be the stuff that everyone's talking about now — fentanyl," Anthony said. "Because I never thought straight heroin would kill him."
Anthony Salemi was familiar with fentanyl. He'd been prescribed the powerful painkiller after surgery in 2006. Anthony had warned his younger brother about reports that dealers were adding an illicit version of the drug to heroin, sometimes promising a more intense high. Fentanyl is more than 50 times more potent than heroin, according the Centers for Disease Control and Prevention.
But people like Joe rarely know for sure if there is fentanyl in the tiny plastic bags of illegal powder they buy — or how much. Just a few grains of pure fentanyl, doctors say, is enough to kill most users. In Massachusetts, 75 percent of the people who overdosed this year tested positive for the drug.
"It just seems like the dealers and the drugs are ravaging the whole country," said Anthony Salemi. "The supply just keeps coming in, no matter how many cops you put at the border, it just keeps coming in. This is scary."
The Obama administration agreed that the increasing supply of fentanyl on the street is a major challenge and said agencies are doing a lot. But reducing the supply is complicated.
Fentanyl is a synthetic opioid, constructed with lab chemicals — unlike heroin or morphine, which start with the opium sap of a poppy plant. Drug enforcement agents said clandestine labs across China are the main source of the illegally sold fentanyl.
Producers then ship the drug to Mexico, where drug cartels mix it into heroin or press it into blue, pink or white tablets that look like prescription pills for anxiety or pain. The powder or pills are delivered to dealers, or directly to users, via the internet or darknet, an online area used for illegal purchases.
"Synthetic drugs are a real winner because they are easy to make, and they're cheap to produce," said Kara McDonald, director of policy, planning and coordination at the international narcotics and law enforcement bureau of the U.S. Department of State.
"They're not dependent on a season or the weather like a plant-based drug," McDonald said. "And with the distribution system — through mail order — they can be delivered directly to the door in some cases. Like a pizza."
The profit margin is huge, said Drug Enforcement Administration spokesperson Russ Baer. He said it costs from $3,000 to $4,000 to produce a kilo — 2.2 pounds — of fentanyl. The fentanyl is then cut with cheap fillers to make pills, or mixed into bags and fraudulently sold as pure heroin.
"Drug traffickers involved in the wholesale distribution of those products can yield close to $1.5 million off that one kilogram," said Baer.
The DEA has six agents who operate out of Beijing and work closely with China's Ministry of Public Security, Baer said. Chinese officials established controls on 116 new chemicals last year, including 19 that have much the same molecular structure as fentanyl. Baer said that helped reduce the supply of some of these designer analogs of the drug. (Though each analog drug has a slightly different chemical structure from fentanyl, they work much the same way in the body.)
And in September, the DEA moved to declare another fentanyl analog called U-47700 illegal. But the producers always seem to be one step ahead of enforcement agencies, Baer said.
"Once we control a substance, whether here in the U.S. or in China, for example," he said, "the drug manufacturers simply change a molecule, tweak a molecule, in an attempt to circumvent the law."
Keeping up with the inventive chemists sounds nearly impossible.
"We're identifying one to two new synthetic substances every week," Baer said.
The international control system is only able to detect, process and outlaw about 10 new psychoactive substances a year, McDonald said. "It doesn't take a mathematician to identify that we have a real challenge here."
If a drug compound is similar to fentanyl, or if it produces the same physiological effect, the DEA can file trafficking charges here in the U.S. But these variations are not illegal in many countries. McDonald said the State Department is working, through the United Nations and with individual nations, to make sure police everywhere can identify new drugs and prosecute dealers.
To get in front of production, the State Department and a group of U.S. senators asked the United Nations in October to add to the list of tightly controlled substances two key ingredients used to make fentanyl. A decision is expected next year.
McDonald and Baer at the DEA said slowing demand for illicit uses of fentanyl and other opioids has become an urgent priority. The office of the U.S. Surgeon General last week also issued a report on the growing problem of substance abuse and the need for more widespread implementation of well-recognized, evidence-based treatment programs to address the problem.
In an interview with NPR's Steve Inskeep on Morning Edition, Surgeon General Vivek Murthy called addiction "a chronic disease of the brain."
"We need to treat it with the same urgency and compassion that we do any other illness," Murthy told Inskeep.
But some lawmakers, physicians and families who've lost loved ones say the Obama administration has done too little too late to tackle the epidemic.
U.S. Sen. Ed Markey, a Democrat from Massachusetts, said it's time to make the illegal production and trafficking of fentanyl the top policy issue in relations with China and Mexico.
"Many more people are going to die from this than [from] any threat from nuclear weapons or any devastation that's caused by an imbalance in trade," Markey said.
Baer said trying to stop the supply of opioids is part of the solution, but so is tackling demand by addressing addiction as a disease.
"The community needs to embrace these folks, create treatment opportunity," Baer said. "We need to educate the public. It's the No. 1 priority and it represents a public health crisis that all of us must work together to try to resolve."
The CDC offers a sobering perspective. While about 78 Americans will die today after an overdose, another 580 will try heroin — or what they think is heroin — for the first time.
This story is part of a partnership that includes WBUR, NPR and Kaiser Health News.
What do those things have to do with the repeal of the Affordable Care Act?
Economists and policymakers think the U.S. may be overpaying for such services, which helps drive up health care expenses for everyone. And the health law has a program that includes testing new ways to pay for care — including in those three areas — that might result in better quality and lower costs.
But with the ACA up for potential repeal, what happens to that testing now? One of the emerging questions is whether Congress will save all or part of that effort, known as the Center for Medicare & Medicaid Innovation.
Republican lawmakers have complained — along with some in the health care industry — that the law under the Obama administration gave too much authority to the head of the Department of Health and Human Services to create and expand projects. Now, however, that very same authority may look appealing as Republicans head the department and may want to use the center to test their own ideas, including those that would revamp Medicare or Medicaid.
"You can dislike that authority, until you have the opportunity to use the authority," said Rodney Whitlock, a vice president at ML Strategies, a government consulting firm in Washington, D.C., and former Republican staff member of the Senate Finance Committee.
As they debate and discuss ways to repeal the Affordable Care Act, lawmakers will weigh the innovation center, funded through the health law with $10 billion for 2011 to 2019, and another $10 billion for each subsequent decade. The Congressional Budget Office estimates the center would increase federal spending initially, but ultimately result in lower costs and save up to $34 billion over the next 10 years.
Congressional Republicans have not yet hinted whether they will keep, modify or kill the program but they generally support the cost-saving goal of the center and many observers think they will want to preserve it.
"If health care providers can do a better job of delivering patient care … at the same or lower costs, that's the kind of flexibility the system needs more of," said Mark McClellan, a professor of health policy at Duke University who headed Medicare for two years under the George W. Bush administration.
One group that generally supports the broad cost-saving goal of the center, nonetheless warned that Congress should place limits on it. Otherwise, "there is nothing preventing [the center] from testing a model … that includes all Medicare and/or Medicaid beneficiaries in the U.S," the Healthcare Leaders for Accountable Innovation in Medicare said in a white paper. "In effect [the center] could test a model that completely restructures the Medicare or Medicaid program."
Billions of dollars have already been spent by the center, testing a variety of ideas, from ways to improve care for at-home dialysis to ways to foster more collaboration between doctors and hospitals to efforts to reduce unnecessary hospital visits by chronically ill Medicare patients. Many of the efforts look at ways to move from Medicare's traditional fee-for-service payment system — that economists and policymakers say drive up costs — and instead set up reimbursement that rewards coordinated care. Few of the projects have been in place long enough for the center to determine if they truly save money and improve care.
Even if the center were eliminated, many experts say these types of payment reforms will continue because of private sector interest.
"Pay-for-value is going to be a guiding principle going forward irrespective of who is in power," said Dan Mendelson, president and CEO of the consulting firm Avalere Health. "It would surprise me to see wholesale U-turn from that policy."
To date, most of the programs funded by the innovation center are voluntary, but controversy has arisen over several recent initiatives that require participation by doctors or hospitals.
What may happen is that there will be fewer of these mandatory efforts. This year, one such project got underway, testing a method of "bundling" payments for joint replacements at 800 hospitals in 67 metro areas. For their Medicare patients, the project requires a single bundled payment to cover the cost of these procedures, including in-patient and post-operative care, instead of separate payments for each doctor, hospital or nursing home visit. A similar mandatory project for certain kinds of cardiac care has also been proposed.
In the end, the center's future will be determined by whether the Republican majority believes it is one of the best ways to slow rising medical costs, said Christopher Condeluci, principal at CC Law & Policy in Washington, D.C., and the former tax and benefits counsel to the Senate Finance Committee.
"If the answer is yes, they will keep it and it might go to new heights," Condeluci said.
But economist Joe Antos, a resident scholar at the American Enterprise Institute, does not think the new administration — or many members of Congress — will push to use the center's authority to create broad, mandatory nationwide experiments with Medicare.
"I can't imagine a Trump administration saying we want the bureaucrats to decide on the health care your grandmother is going to get," said Antos. "Anything that is that much of a marquee issue absolutely has to go through Congress."
Seema Verma comes to the job with extensive Medicaid experience. Her consulting firm worked closely with Indiana Gov. Mike Pence to design Indiana's Medicaid expansion under the Affordable Care Act.
On Tuesday, President-elect Donald Trump tapped Seema Verma, a health care consultant, to head the Centers for Medicare and Medicaid Services. That's the part of the Department of Health and Human Services that oversees Medicare, Medicaid, and the Children's Health Insurance Program and has a budget of just under a trillion dollars in 2016.
Verma comes to the job with extensive Medicaid experience. Her consulting firm, SVC, Inc., worked closely with Indiana Gov. Mike Pence to design Indiana's Medicaid expansion under the Affordable Care Act. The expansion, known as the Healthy Indiana Plan or HIP 2.0, went into effect early last year, and Verma's involvement may be important as Congress and the Trump administration, including the vice-president elect, make decisions on the future of the ACA.
Indiana's unique Medicaid expansion was designed to appeal to conservatives. HIP 2.0 asks covered people to make a small monthly payment to access health insurance. A missed payment can result in six-month lockout from insurance coverage. Those provisions aren't allowed under traditional Medicaid, but Indiana got special permission from CMS to implement them through a waiver.
Other Republican-led states such as Iowa, Ohio and Kentucky, have contracted with Verma's firm to help submit their own Medicaid expansion proposals to the federal government that also include conservative provisions such as asking recipients to pay for some of their care, or requiring them to work or be actively looking for work.
Susan Jo Thomas, who heads the Indiana insurance advocacy group Covering Kids and Families, said Verma's contributions to HIP 2.0 made Medicaid expansion possible in a Republican state. "She understood that in order to get expansion in this state," she said. "It's more about what is palatable, what can get approved."
Nearly 410,000 people are members of HIP 2.0, according to the latest data from the state.
But HIP 2.0 has its critics. David Machledt, a policy analyst with the National Health Law Program, which advocates for health care for low-income individuals, argued that the cost-sharing provisions or if a person is temporarily removed from Medicaid actually reduce participation in the program. "Early evaluations show that a lot of people don't understand this plan and don't understand the incentives in it," he said. That means people end up not getting the health care they need.
Nevertheless, Machledt said if Medicaid expansion continues, Verma's pick to head CMS could mean that proposals similar to Indiana's may be more likely to be approved.
Joan Alker with the Georgetown Center for Children and Families agrees, and finds it worrisome. "It is a good thing that she has experience with Medicaid and it is a positive that Governor Pence worked with Ms. Verma to advance a version of Medicaid expansion," she said. "But I think if you look at the totality of the Trump administration's picks today — Congressman Price as well as Ms. Verma — this represents potentially a very damaging and chaotic restructuring of the Medicaid program." Price has advocated severely cutting Medicaid funding, and Alker worries that cuts and more stringent requirements under Verma mean people will lose the health insurance.
"The Healthy Indiana Plan has occurred in the context of generous federal funding," she said. "And I think some of that is on deck to go away."
But Verma may be a smart pick, said Indiana Rep. Charlie Brown, the ranking Democrat in the state's public health committee. "She is a smooth operator, and very, very persuasive," he said. Brown worked in opposition to Verma in crafting the Healthy Indiana Plan, but said she worked effectively across party lines to incorporate the Pence administration's wishes into the program.
"She's very resourceful and intelligent," said Brown. "But the question now becomes, 'What will be her marching orders as they relate to Medicare and Medicaid?' "
Verma's role in shaping Indiana's health care policy has had some controversy. According to a 2014 report from The Indianapolis Star, she has received millions of dollars from the state through her work with the Indiana government. She was also paid by Hewlett-Packard, a Medicaid vendor that received more than $500 million in state contracts. Government ethics experts told the Star the arrangement presented a conflict of interest.
Verma did not immediately respond to requests for comment, nor did Gov. Pence's office.
A transitional care clinic in San Antonio helps the mentally ill avoid winding up in the ER, where round-the-clock activity and confusion is ill-suited to the needs of patients who are already agitated, suicidal or psychotic.
SAN ANTONIO— Yolanda Solar has battled a life-threatening disease for more than three decades.
The disease nearly killed her last summer, and Solar, a 73-year-old grandmother, was rushed to the hospital by ambulance.
When Solar was discharged one week later, she received bad news: She would have to wait until March to see a doctor.
Waiting seven months for treatment would be unthinkable if Solar had cancer or heart disease. But Solar suffers from severe depression, and waiting that long for help is typical — and potentially dangerous.
Although San Antonio has earned widespread praise for its success in keeping people with mental illness out of jail, patients here routinely wait months to see psychiatrists, who are in short supply across the country. The number of available psychiatrists who specialize in the care of the elderly or children is even smaller.
Without routine medical care, patients like Solar, who tried to kill herself in August with an overdose of pills, can quickly deteriorate. Many return to the emergency room. Some don't survive.
But Solar was luckier than most.
Emergency room staff made an appointment for her at a transitional care clinic at the University of Texas Health Science Center at San Antonio, which annually treats up to 1,500 patients with serious mental illness until they can find regular care. The clinic helps the mentally ill avoid winding up in the ER, where round-the-clock activity and confusion is ill-suited to the needs of patients who are already agitated, suicidal or psychotic.
Communities like San Antonio are increasingly focused on reducing emergency room use by people with mental illness. In addition to being chaotic, emergency rooms are among the most expensive places in the health system to get urgent care.
Patients like Solar end up in the ER because they can't find care in the community, and emergency rooms can't legally turn anyone away. The mentally ill can be stranded in the ER for hours, days or even weeks with minimal treatment, because doctors deem them too disabled to discharge, but can't find them an inpatient psychiatric bed, which would allow patients to get more intensive care.
More than half of emergency room physicians said their local mental health system has gotten worse in the past year, according to a survey of 1,716 members of the American College of Emergency Physicians, released in October. Seventy-five percent of ER doctors said on their last shift, they saw at least one psychiatric patient who needed to be hospitalized.
"The emergency department becomes the de facto dumping ground for all mental health patients," said Gillian Schmitz, a San Antonio emergency physician.
The number of ER patients with a mental illness grew from 4.4 million in 2002 to 6.8 million in 2011, an increase of 55 percent, according to a 2016 study in Health Affairs. About 836,000 Americans a year go to the emergency room after harming themselves, according to the Centers for Disease Control and Prevention. Nearly 43,000 Americans committed suicide in 2014 — more than are killed annually in car accidents.
The American College of Emergency Physicians devoted much of its annual meeting in October to patients with psychiatric crises.
Everyone suffers when people with mental illness are stuck in limbo in the ER, Schmitz said. Other patients face longer waits for care and hospitals lose money. That's because insurers pay emergency rooms only for their initial encounter with a patient, but not for time spent waiting for an inpatient bed.
"Every hour we are holding a psych patient," Schmitz said, "is lost revenue that hospitals could be earning on other medical patients."
Personalized care
Solar's story also shows the progress that people with mental illness can make when they receive prompt and comprehensive care. She has not returned to the ER since beginning treatment in August.
Hospital staff scheduled her appointment at the transitional care clinic through a web-based computer system before she left the hospital. Like most patients, Solar was seen within a few days.
Solar now meets regularly with a psychiatrist, who manages her medications, and a counselor to discuss her fears.
A therapist visits her at home to help organize her medications, which include pills for high blood pressure and cholesterol. The visits are paid for through a Medicaid pilot program, which allows staff to provide extra services for up to five patients who are considered "high utilizers" of health care, or patients who are particularly costly to insurers because of repeat trips to the hospital or ER, said Megan Fredrick, the clinic's program manager.
Patients with serious mental illness, which can cause cognitive changes similar to dementia, often need help with day-to-day tasks, said psychologist Dawn Velligan, project director at the transitional care clinic. Therapists help patients set alarms that remind them when to take their medicines. They work with patients on calendars and organizational skills, so that clients don't miss appointments.
Through a type of therapy called cognitive adaption training, clinic staff teach basic skills, such as how to shop for groceries or take the bus to a medical appointment, Velligan said.
Only 2.5 percent of psychiatric patients seen at the transitional care clinic return to the ER within three months, compared to 10 percent of patients who aren't seen at the clinic, Fredrick said.
Without the clinic's help, Solar said, she would probably have considered suicide again.
"Sometimes, I get pretty, pretty, pretty depressed," said Solar, who was raised by an alcoholic father. Her depression began, Solar said, during an unhappy marriage.
Yet for years, Solar suffered in silence. The first time she saw a psychiatrist was after her August suicide attempt.
Nationwide, more than half of people with mental illness go without treatment, according to Mental Health America, an advocacy group. The reasons are complex. Many people with mental illness don't realize they're sick, or that treatment can help. Some patients lack transportation or money to pay for care. About 17 percent of people with a mental illness in the U.S. are uninsured, according to Mental Health America.
"For many of our elderly Hispanic patients, this is the first time they've seen a therapist," Cynthia Sierra, a clinic counselor. "You're raised not to talk about your problems with strangers … You can carry years of burdens and trauma."
Unsolved problems
For all its success, the transitional care clinic can't help everyone.
With an annual budget of $3.5 million — provided by a variety of grants and a fund for Medicaid demonstration projects — the clinic sees just a fraction of those who need help.
"We constantly have to beg for money," Velligan said.
Although the transitional clinic accepts patients covered by Medicare, Medicaid or private insurance, it can't accept most uninsured patients.
Psychiatrist Harsh Trivedi describes the program as a "Band-Aid" that fails to address the larger problem of inadequate care for people with mental illness.
"Unfortunately, creating these programs doesn't actually solve the real access issues," said Trivedi, chair of the American Psychiatric Association's council on healthcare systems and financing.
Trivedi notes that the national shortage of psychiatrists means that even well-insured patients often have to wait for care. Although the overall number of physicians increased 14 percent from 2003 to 2013, the number of psychiatrists fell by 10 percent when adjusted for population growth, according to a July study in Health Affairs.
That shortage is projected to worsen over the next decade as large numbers of psychiatrists reach retirement age, said Trivedi, who is also the president and CEO of Sheppard Pratt Health System in Maryland.
Many psychiatrists have stopped taking insurance because health plans pay them too little to sustain a practice, Trivedi said.
To really help more patients, the country needs to rebuild the mental health system, investing both in outpatient care, more hospitals beds and supportive services, Schmitz said. Instead, states have been steadily slashing mental health budgets for years.
"As a society, we're OK with the fact that someone with depression isn't able to get care," Trivedi said. "That double standard allows some of our most vulnerable people to end up in harm's way."
Six years into building its business around the Affordable Care Act, the nation's $3 trillion health care industry may be losing that political playbook.
Industry leaders, like many voters, were stunned by the election of Donald Trump and unprepared for Republicans' plans to "repeal and replace" Obamacare.
In addition, Trump's vague and sometimes conflicting statements on health policy have left industry officials guessing as to the details of any substitute for the federal health law.
"It will be repealed and replaced," Trump said Sunday in an interview on CBS' "60 Minutes." At the same time, he vowed to preserve popular provisions of the law like ensuring that people with preexisting conditions can get insurance and allowing young adults to stay on their parents' health plans.
Charles (Chip) Kahn, chief executive of the Federation of American Hospitals, said that before the election, health groups had not been meeting with Republicans about a rewrite of the law "because the working assumption was we had a program that wasn't going anywhere. That working assumption is now no longer operative."
Upending the health law plays havoc with a health industry that had invested heavily in strategies geared to the ACA's financial incentives. The flipped script initially left some industry groups speechless. Others issued bland statements pledging cooperation with the next administration as they awaited greater clarity from the next president.
Said Donald Crane, who heads CAPG, a national trade group for physician organizations: "Nobody was ready for this. We didn't have a Plan B."
The results appear to have rattled the fragile industry coalition that the Obama administration carefully crafted to support the law. Looking ahead, some health sectors might have even more reason to worry.
The hospital industry may be the most vulnerable to proposed changes, which could result in millions of Americans losing health coverage, both through the insurance exchanges and expansion in the Medicaid program for those with lower incomes.
Hospitals cut a deal with Congress and the Obama administration in 2009, when the Affordable Care Act was being drafted. They agreed to substantial cuts in Medicare and Medicaid reimbursement, anticipating that those cuts would be offset by increases in paying customers who were newly insured.
"If you're a hospital, you've sort of made this deal that you're going to get more coverage [so you] accepted Medicare cuts," said Dean Rosen, a longtime Republican congressional staffer who now represents hospital, insurance and other health interests in Washington. "What's going to happen now?"
If expanded coverage under Obamacare goes away, said Kahn, then those cuts should be restored, "because those were done with the notion that uninsured people were going to have coverage."
Other sectors of the industry appear either at somewhat less risk, or could even come out ahead under Trump and a Republican Congress.
While the pharmaceutical industry would stand to lose paying customers if the law was changed in a way that people lose insurance coverage, it could actually be a winner under a Republican president and Congress. That's because the industry will be less at risk of the price controls that Democrats were vowing to try to impose. Trump mentioned drug prices a few times on the campaign trail, but references to drug pricing are not on the health agenda outlined on the transition website.
Insurers express mixed feelings about a potential repeal. The government-run exchanges where consumers can purchase federally subsidized coverage are a key pillar of Obamacare. But many insurers have complained about losing money in those marketplaces because too many sick people are signing up and healthier consumers are sitting out.
Some industry executives predict that the exchanges will be curtailed and Republicans will try to shift some of that coverage to state Medicaid programs. One of the biggest growth opportunities for insurers under Obamacare has been the expansion of Medicaid managed-care contracts under which private firms take responsibility for a large group of low-income enrollees for a fixed amount of money.
That privatization of Medicaid could accelerate under the Trump administration, some experts predict.
"Whether it's Medicaid managed care or the private insurance model, these companies get their money either way," said Paul Ginsburg, a health economist and professor at the University of Southern California. "I don't see much of a threat to insurers."
The picture is even rosier considering the insurance industry dodged a debate about a government-run public option, backed by Democratic presidential nominee Hillary Clinton, that would have competed directly against private health plans.
The proposed changes extend beyond the health law. Many insurers expect Republicans to champion an expansion of privately run Medicare Advantage plans. These alternative plans often offer additional health benefits not covered by traditional Medicare, but they were targeted in the health law for cutbacks because back then they were more expensive to the government than traditional Medicare.
"Medicare Advantage is poised to be the big winner consistent with Republican support of privatizing Medicare," said Ana Gupte, a health care analyst at Leerink Research.
Nothing on health care is bound to change right away. Republicans have promised to put their early focus on the health law, but even with a quick vote on repealing major parts of it, they are expected to set a lengthy transition period that keeps the current framework in place while a replacement plan is developed. At that point, Republicans will encounter many of the tough choices Democrats struggled with while writing the landmark 2010 health law. They spent more than two years trying to craft intricate compromises among industry leaders.
"The Republicans will face the same issues as the architects of the Affordable Care Act," said Crane. "How do we fund it? Whose scalp do you take? And how do you get the most people covered for the lowest cost at the highest quality?"
Jeff Goldsmith, a health industry consultant in Charlottesville, Va., said the Republicans are "starting from zero in dealing with this. They have no idea about the subtleties."
Some industry leaders are encouraged that Trump has softened his talk of "repeal and replace" and seems open to keeping at least some of the provisions of the health law.
Bernard Tyson, CEO of Kaiser Permanente, a large health system and insurer based in Oakland, Calif., took some comfort from Trump's own words.
He "said no one in this country should suffer unnecessarily because they can't afford health care. That tells me we have room to work here," Tyson said. "I believe when they get under the hood of the Affordable Care Act, I think we may start to see and hear different conversations."
Ginsburg predicts that Trump might apply his marketing skills to health reform.
"If you really want to continue with 20 million people having coverage," Ginsburg said, "it will kind of look like the Affordable Care Act. There will be rebranding, but a lot of the elements will remain."